FindTrial
Sign In

Trin Panchmool Kwath in Hypertension

A Clinical Study to Evaluate the Antihypertensive Effect of Trin Panchmool Kwath in the Management of Essential Hypertension

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/11/022015
Enrollment
30
Registered
2019-11-15
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

Intervention1: Trinpanchmool Kwath: 50 ml twice a day for 45 days duration Control Intervention1: Tab Chlorthalidone: 12.5mg once a day for 45 days duration

Sponsors

Principal Rajiv Gandhi government Ayurvedic college Paprola
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patient willing for trial 2 Patients in age group between 20 to 70 years 3 Patient suffering from stage 1 hypertension 4 Patients suffering from isolated systolic hypertension

Exclusion criteria

Exclusion criteria: 1 Patient not willing for the trial 2 Patient 70 years of age 3 Stage II hypertension 4 Patient suffering from secondary hypertension 5 Any other patients considered unfit for the inclusion in trial after investigation 6 Patient who had participated in any clinical study/ trial in past 6 months

Design outcomes

Primary

MeasureTime frame
Fulfillment of objective and subjective criteriaTimepoint: 45 days—

Secondary

MeasureTime frame
Blood Pressure decreaseTimepoint: 45 days—

Countries

India

Contacts

Public ContactPrerna

RAJIV GANDHI AYURVEDIC COLLEHE AND HOSPITAL PAPROLA DISTRICT KANGRA HIMACHAL PRADESH(HPU)

drvijaychaudhary@gmail.com9418130228

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026